Lupron Depot-ped Kit
Product Images NDC 0074-3575

16 FDA label images from Abbvie Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Lupron Depot-ped (NDC 0074-3575). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Abbvie Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Lupron Depot Ped Spl 01)

Figure 1 (Lupron Depot Ped Spl 01)
An illustration diagram of a prefilled syringe labeled with components of the Lupron Depot-PED leuprolide acetate kit. Parts identified include the plunger, finger grip, end stopper, diluent, middle stoppers, leuprolide acetate microsphere powder, barrel with a blue line, front stopper, needle and cap, and the LuproLoc safety device.*
FDA Label Image

Figure 2 (Lupron Depot Ped Spl 02)

Figure 2 (Lupron Depot Ped Spl 02)
An instructional illustration showing two hands preparing a syringe by attaching or securing a component with a twisting motion, likely demonstrating a step in the use or assembly of a Lupron Depot-PED kit syringe.*
FDA Label Image

Blue Line (Lupron Depot Ped Spl 03)

Blue Line (Lupron Depot Ped Spl 03)
An instructional illustration showing a hand holding a syringe with an arrow indicating upward movement of the plunger, and a label pointing to a 'blue line' on the syringe barrel. This diagram appears related to the administration or preparation of Lupron Depot-PED (leuprolide acetate) kit.*
FDA Label Image

Syringe Shake (Lupron Depot Ped Spl 04)

Syringe Shake (Lupron Depot Ped Spl 04)
An instructional black-and-white line drawing showing a hand holding a syringe. The illustration includes arrows pointing left and right, indicating a back-and-forth motion for preparing or mixing the syringe contents. No product text or labels are visible in the image.*
FDA Label Image

Figure 5 (Lupron Depot Ped Spl 05)

Figure 5 (Lupron Depot Ped Spl 05)
An instructional diagram showing four potential injection sites on the human body, including the upper arm, buttock, thigh, and abdomen. It also demonstrates the technique of holding a syringe at a 90-degree angle for injection.*
FDA Label Image

Lupro Loc (Lupron Depot Ped Spl 06)

Lupro Loc (Lupron Depot Ped Spl 06)
An instructional diagram showing a close-up view of a device or mechanism with a lever and protruding part, highlighted by a bold arrow pointing to a specific area, likely indicating an operational step or component detail for Lupron Depot-PED kit use.*
FDA Label Image

Click One (Lupron Depot Ped Spl 07)

Click One (Lupron Depot Ped Spl 07)
An instructional line drawing showing a hand holding a device, with an upward arrow above and a black arrow pointing down on the device, indicating a step in the use or activation of the device.*
FDA Label Image

Lupron Structure (Lupron Depot Ped Spl 08)

Lupron Structure (Lupron Depot Ped Spl 08)
Chemical structure diagram of leuprolide acetate, the active ingredient in Lupron Depot-PED. The diagram depicts the molecular configuration with amino acid residues and functional groups characteristic of this peptide compound.*
FDA Label Image

Figure 1. Mean Peak Stimulated Lh For Lupron Depot-ped 11.25 mg For 3-month Administration (Lupron Depot Ped Spl 09)

Figure 1. Mean Peak Stimulated Lh For Lupron Depot-ped 11.25 mg For 3-month Administration (Lupron Depot Ped Spl 09)
A line graph showing mean plus SE stimulated LH (mIU/mL) over 24 study weeks. It compares two groups: 11.25 mg naive and 11.25 mg previously treated, with a reference line at 4 mIU/mL. Both groups show a sharp decline from baseline to week 4 and then remain near or below the reference line through week 24.*
FDA Label Image

Figure 2. Mean Peak Stimulated Lh For Lupron Depot-ped 30 mg For 3-month Administration (Lupron Depot Ped Spl 0a)

Figure 2. Mean Peak Stimulated Lh For Lupron Depot-ped 30 mg For 3-month Administration (Lupron Depot Ped Spl 0a)
A line chart displaying mean plus standard error (SE) stimulated luteinizing hormone (LH) levels in mIU/mL over a 24-week study period. The graph compares two groups: 30 mg naive and 30 mg previously treated, showing LH levels dropping sharply by week 4 and remaining low through week 24. A 4 mIU/mL reference line is also present.*
FDA Label Image

Ndc 0074-2108-03 Pediatric Use Only 7.5 mg For 1-month Administration Single Dose Administration Kit With Prefilled Dual-chamber Syringe. Lupron Depot-ped®(leuprolide Acetate For Depot Suspension) Dispense The Accompanying Medication Guide To Each Patient. 7.5 mg For 1-month Administration For Intramuscular Injection The Front Chamber Contains: Leuprolide Acetate 7.5 mg۰purified Gelatin 1.3 mg۰dl-lactic & Glycolic Acids Copolymer 66.2 mg۰d-mannitol 13.2 mg The Second Chamber Contains: D-mannitol 50 mg۰ Carboxymethylcellulose Sodium 5 mg۰polysorbate 80 1 mg۰water For Injection, Usp And Glacial Acetic Acid, Usp To Control Ph Rx Only (Lupron Depot Ped Spl 0b)

Ndc 0074-2108-03 Pediatric Use Only 7.5 mg For 1-month Administration Single Dose Administration Kit With Prefilled Dual-chamber Syringe. Lupron Depot-ped®(leuprolide Acetate For Depot Suspension) Dispense The Accompanying Medication Guide To Each Patient. 7.5 mg For 1-month Administration For Intramuscular Injection The Front Chamber Contains: Leuprolide Acetate 7.5 mg۰purified Gelatin 1.3 mg۰dl-lactic & Glycolic Acids Copolymer 66.2 mg۰d-mannitol 13.2 mg The Second Chamber Contains: D-mannitol 50 mg۰ Carboxymethylcellulose Sodium 5 mg۰polysorbate 80 1 mg۰water For Injection, Usp And Glacial Acetic Acid, Usp To Control Ph Rx Only (Lupron Depot Ped Spl 0b)
Lupron Depot-PED (leuprolide acetate) Kit 11.25 mg for 1-month administration, shown on a product label. The label specifies single dose administration with the provided dual-chamber syringe, for intramuscular injection. Manufactured by AbbVie Inc., the label includes dosage details, lot and expiration information, as well as handling instructions and storage conditions.*
FDA Label Image

Ndc 0074-2282-03 Pediatric Use Only 11.25 mg For 1-month Administration Single Dose Administration Kit With Prefilled Dual-chamber Syringe. Lupron Depot-ped®(leuprolide Acetate For Depot Suspension) Dispense The Accompanying Medication Guide To Each Patient. 11.25 mg For 1-month Administration For Intramuscular Injection The Front Chamber Contains: Leuprolide Acetate 11.25 mg۰purified Gelatin 1.95 mg۰dl-lactic & Glycolic Acids Copolymer 99.3 mg۰d-mannitol 19.8 mg The Second Chamber Contains: D-mannitol 50 mg۰carboxymethylcellulose Sodium 5 mg۰polysorbate 80 1 mg۰water For Injection, Usp, And Glacial Acetic Acid, Usp To Control Ph Rx Only (Lupron Depot Ped Spl 0c)

Ndc 0074-2282-03 Pediatric Use Only 11.25 mg For 1-month Administration Single Dose Administration Kit With Prefilled Dual-chamber Syringe. Lupron Depot-ped®(leuprolide Acetate For Depot Suspension) Dispense The Accompanying Medication Guide To Each Patient. 11.25 mg For 1-month Administration For Intramuscular Injection The Front Chamber Contains: Leuprolide Acetate 11.25 mg۰purified Gelatin 1.95 mg۰dl-lactic & Glycolic Acids Copolymer 99.3 mg۰d-mannitol 19.8 mg The Second Chamber Contains: D-mannitol 50 mg۰carboxymethylcellulose Sodium 5 mg۰polysorbate 80 1 mg۰water For Injection, Usp, And Glacial Acetic Acid, Usp To Control Ph Rx Only (Lupron Depot Ped Spl 0c)
Lupron Depot-PED 11.25 mg for 3-month administration kit for pediatric use. The label indicates it contains leuprolide acetate in a depot suspension form for intramuscular injection. It includes instructions emphasizing pediatric administration, a dual-chamber syringe, and storage information. The product is labeled by AbbVie Inc.*
FDA Label Image

Ndc 0074-2440-03 Pediatric Use Only 15 mg For 1-month Administration Single Dose Administration Kit With Prefilled Dual-chamber Syringe. Lupron Depot-ped®(leuprolide Acetate For Depot Suspension) Dispense The Accompanying Medication Guide To Each Patient. 15 mg For 1-month Administration For Intramuscular Injection The Front Chamber Contains: Leuprolide Acetate 15 mg۰purified Gelatin 2.6 mg۰dl-lactic & Glycolic Acids Copolymer 132.4 mg۰d-mannitol 26.4 mg The Second Chamber Contains: D-mannitol 50 mg۰ Carboxymethylcellulose Sodium 5 mg۰polysorbate 80 1 mg۰water For Injection, Usp And Glacial Acetic Acid, Usp To Control Ph Rx Only (Lupron Depot Ped Spl 0d)

Ndc 0074-2440-03 Pediatric Use Only 15 mg For 1-month Administration Single Dose Administration Kit With Prefilled Dual-chamber Syringe. Lupron Depot-ped®(leuprolide Acetate For Depot Suspension) Dispense The Accompanying Medication Guide To Each Patient. 15 mg For 1-month Administration For Intramuscular Injection The Front Chamber Contains: Leuprolide Acetate 15 mg۰purified Gelatin 2.6 mg۰dl-lactic & Glycolic Acids Copolymer 132.4 mg۰d-mannitol 26.4 mg The Second Chamber Contains: D-mannitol 50 mg۰ Carboxymethylcellulose Sodium 5 mg۰polysorbate 80 1 mg۰water For Injection, Usp And Glacial Acetic Acid, Usp To Control Ph Rx Only (Lupron Depot Ped Spl 0d)
Drug facts panel for Lupron Depot-PED (leuprolide acetate) 30 mg for 3-month administration pediatric kit. The panel includes dosage instructions, administration warnings, product NDC code, company information (AbbVie Inc.), and a patient notice to dispense the accompanying Medication Guide. It specifies intramuscular injection and pediatric use only.*
FDA Label Image

Ndc 0074-3779-03 Pediatric Use Only 11.25 mg For 3-month Administration Single Dose Administration Kit With Prefilled Dual-chamber Syringe. Lupron Depot-ped® (leuprolide Acetate For Depot Suspension) Dispense The Accompanying Medication Guide To Each Patient. 11.25 mg For 3-month Administration For Intramuscular Injection The Front Chamber Contains: Leuprolide Acetate 11.25 mg۰polylactic Acid 99.3 mg۰d-mannitol 19.45 mg The Second Chamber Contains: Carboxymethylcellulose Sodium 7.5 mg۰d-mannitol 75.0 mg۰polysorbate 80 1.5 mg۰water For Injection, Usp, And Glacial Acetic Acid, Usp To Control Ph Rx Only (Lupron Depot Ped Spl 0e)

Ndc 0074-3779-03 Pediatric Use Only 11.25 mg For 3-month Administration Single Dose Administration Kit With Prefilled Dual-chamber Syringe. Lupron Depot-ped® (leuprolide Acetate For Depot Suspension) Dispense The Accompanying Medication Guide To Each Patient. 11.25 mg For 3-month Administration For Intramuscular Injection The Front Chamber Contains: Leuprolide Acetate 11.25 mg۰polylactic Acid 99.3 mg۰d-mannitol 19.45 mg The Second Chamber Contains: Carboxymethylcellulose Sodium 7.5 mg۰d-mannitol 75.0 mg۰polysorbate 80 1.5 mg۰water For Injection, Usp, And Glacial Acetic Acid, Usp To Control Ph Rx Only (Lupron Depot Ped Spl 0e)
Lupron Depot-PED 7.5 mg kit label by AbbVie Inc. for pediatric use only, intended for 1-month intramuscular injection administration. The label includes instructions to dispense an accompanying Medication Guide, details of the kit components including a prefilled dual-chamber syringe, and safety information. Manufacturer and storage information are also provided.*
FDA Label Image

Ndc 0074-9694-03 Pediatric Use Only 30 mg For 3-month Administration Single Dose Administration Kit With Prefilled Dual-chamber Syringe Lupron Depot-ped®(leuprolide Acetate For Depot Suspension) Dispense The Accompanying Medication Guide To Each Patient. 30 mg For 3-month Administration For Intramuscular Injection The Front Chamber Contains: Leuprolide Acetate 30 mg۰polylactic Acid 264.8 mg۰d-mannitol 51.9 mg The Second Chamber Contains: Carboxymethylcellulose Sodium 7.5 mg۰d-mannitol 75.0 mg۰polysorbate 80 1.5 mg۰water For Injection, Usp, And Glacial Acetic Acid, Usp To Control Ph Rx Only (Lupron Depot Ped Spl 0f)

Ndc 0074-9694-03 Pediatric Use Only 30 mg For 3-month Administration Single Dose Administration Kit With Prefilled Dual-chamber Syringe Lupron Depot-ped®(leuprolide Acetate For Depot Suspension) Dispense The Accompanying Medication Guide To Each Patient. 30 mg For 3-month Administration For Intramuscular Injection The Front Chamber Contains: Leuprolide Acetate 30 mg۰polylactic Acid 264.8 mg۰d-mannitol 51.9 mg The Second Chamber Contains: Carboxymethylcellulose Sodium 7.5 mg۰d-mannitol 75.0 mg۰polysorbate 80 1.5 mg۰water For Injection, Usp, And Glacial Acetic Acid, Usp To Control Ph Rx Only (Lupron Depot Ped Spl 0f)
Lupron Depot-PED kit label for pediatric use only, containing leuprolide acetate 15 mg for 1-month intramuscular injection. The label details kit components including syringes and needles, dosing instructions, and safety warnings. It is labeled by AbbVie Inc. and includes a QR code, lot number, and expiration date fields.*
FDA Label Image

Ndc 0074-3575-01 Pediatric Use Only 45 mg For 6-month Administration Single Dose Administration Kit With Prefilled Dual-chamber Syringe Lupron Depot-ped®(leuprolide Acetate For Depot Suspension) Dispense The Accompanying Medication Guide To Each Patient.45 mg For 6-month Administration For Intramuscular Injection The Front Chamber Contains: Leuprolide Acetate 45 mg۰polylactic Acid 169.9 mg۰d-mannitol 39.7 mg۰stearic Acid 10.1 mg The Second Chamber Contains: Carboxymethylcellulose Sodium 7.5 mg۰d-mannitol 75.0 mg۰polysorbate 80 1.5 mg۰water For Injection, Usp, And Glacial Acetic Acid, Usp To Control Ph Rx Only (Lupron Depot Ped Spl 10)

Ndc 0074-3575-01 Pediatric Use Only 45 mg For 6-month Administration Single Dose Administration Kit With Prefilled Dual-chamber Syringe Lupron Depot-ped®(leuprolide Acetate For Depot Suspension) Dispense The Accompanying Medication Guide To Each Patient.45 mg For 6-month Administration For Intramuscular Injection The Front Chamber Contains: Leuprolide Acetate 45 mg۰polylactic Acid 169.9 mg۰d-mannitol 39.7 mg۰stearic Acid 10.1 mg The Second Chamber Contains: Carboxymethylcellulose Sodium 7.5 mg۰d-mannitol 75.0 mg۰polysorbate 80 1.5 mg۰water For Injection, Usp, And Glacial Acetic Acid, Usp To Control Ph Rx Only (Lupron Depot Ped Spl 10)
Lupron Depot-PED kit containing 45 mg leuprolide acetate for 6-month intramuscular injection, labeled for pediatric use only. The label includes detailed dosing instructions, a barcode, lot number, and expiration date, and states it is manufactured by AbbVie Inc. It also features product warnings, usage instructions, and a black-and-white photo of a child. The kit includes a prefilled dual-chamber syringe for administration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.